The research team led by Senior Researchers Yoonhee Lee from the Division of Biomedical Technology and Gyogwon Koo from the ...

The Global Exosome Market 2024: Two Exosome-based Diagnostics have Received Fast Track Approval from the U.S. FDA - ResearchAndMarkets.com September 16, 2024 10:41 AM Eastern Daylight Time ...

The company’s novel exosome-based technology platform, ExoLution™, and point of care instrument for protein capture and analysis, Shahky TM, can yield comprehensive and dynamic molecular ...

Liquid biopsy, a noninvasive method used for analysis of circulating biomarkers like tumor cells, DNA, and exosomes from bodily fluids, shows promise in advancing cancer research for future diagnostic ...

Furthermore, exosomes must be extracted from a blood sample to do this kind of detection. This is tricky because exosomes are small—measuring just 30 to 200 nanometers (a millionth of a millimeter).

SAN DIEGO--(BUSINESS WIRE)--Biological Dynamics, Inc., a leader in exosome-isolation technology for early disease detection, announced a newly published study in Nature’s Communications Medicine ...

The technology developed by Exosome Diagnostics, the Shahky System, will be used by Dr. Hyungsoon Im, an Assistant Professor of Radiology at MGH, in collaboration with Dr. Lee, to improve upon the ...

Qian, Q., et al. (2023). Microfluidic magnetic detection system combined with a DNA framework-mediated immune-sandwich assay for rapid and sensitive detection of tumor-derived exosomes.

An investigational exosome-based liquid biopsy accurately detected 97% of stage 1-2 pancreatic cancers when combined with the biomarker CA 19-9, according to research presented at the American ...